Narcolepsy Market is estimated to be US$ 4.205 billion by 2030 with a CAGR of 8.9% during the forecast period

 




Narcolepsy market accounted for US$ 1.797 billion in 2020 and is estimated to be US$ 4.205 billion by 2030 and is anticipated to register a CAGR of 8.9%. Narcolepsy is a medical condition marked by excessive daytime sleepiness and irregular sleep patterns. As a result of this chronic sleep disorder, an abrupt loss of muscular tone (cataplexy) can occur, resulting in weakness and loss of muscle control. Sleep paralysis, hallucinations, daytime sleepiness, fragmented sleep, and insomnia are some of the most common symptoms of the illness. Cataplexy, a rapid decrease of muscle strength that has been found to have a major influence on patients' emotional well-being, affects about 70% of persons. Inability to move or vivid hallucinations may occur when falling asleep or waking up.

The report " Global Narcolepsy Market, By Type (Type 1 and Type 2 Narcolepsy), By Treatment (Antidepressants, Stimulants, Sodium oxybate and Others), By Diagnosis (Poysomnogram, Multiple sleep latency test and Others), By End Users (Hospitals, Retail Pharmacies) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Highlights:

  • Adare Pharmaceuticals and NLS Pharmaceutics teamed together in January 2020 to develop a mazindol CR product candidate for the treatment of narcolepsy and attention deficit hyperactivity disorder (ADHD).

Analyst View:

The key factors pushing the market for narcolepsy drugs to increase are the severity of the disease and the number of people affected by it. Sleep apnea can be treated using narcolepsy drugs. Demand is further boosted by the availability of a payment method for FDA-approved prescription medications. Additionally, rising disposable income and increased awareness of the benefits of narcolepsy drugs are likely to propel the global market forward. Rising narcolepsy prevalence and a growing obese population are the key factors of narcolepsy market growth over the forecast period.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230

 

Key Market Insights from the report:

The global Narcolepsy market accounted for US$ 1.797 billion in 2020 and is estimated to be US$  4.205 billion by 2030 and is anticipated to register a CAGR of 8.9%. The Global Narcolepsy Market is segmented based on the type, treatment, diagnosis, end-user, and region.

·       

  • By Type, the Global Narcolepsy Market is segmented into Type 1 and Type 2.
  • By Treatment, the market is segmented in Antidepressants, Stimulants, Sodium oxybate and Others.
  • By Diagnosis, the Global Narcolepsy Market is segmented into Poysomnogram, Multiple sleep latency test and Others.
  • By Region, the Global Narcolepsy Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. America dominates the global narcolepsy market.

Competitive Landscape:

The key players operating in the global Narcolepsy market includes Jazz Pharmaceuticals plc., BIOPROJET, Arena Pharmaceuticals, Inc., Graymark Healthcare, Inc., Mylan N.V.  Teva Pharmaceutical Industries Ltd., Novartis AG, Shire, Shionogi Inc., Ligand Pharmaceuticals, Inc., and Others.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. 

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Patient Portal Market is estimated to be US$ 7862.01 billion by 2030 with a CAGR of 11.50% during the forecast period

Image
  Patient Portal Market  accounted for US$ 2643.21 million in 2020 and is estimated to be US$ 7862.01 million by 2030 and is anticipated to register a CAGR of 11.50%. The patients can share and view their health information and communicate remotely. These characteristics enables patients to look into various data points, such as diagnostic test results, medical history, and prescription information. Patient portal is one of the many tools that allow the healthcare payers and providers to arrive at outcomes, which are patient-centric. Rapid technological advancements in the digital space are rising the engagement level of patients in the entire healthcare ecosystem. Data points collected on a per-patient basis through patient portal can be used for performing pin-point diagnosis, designing better clinical trials, and helping in the elimination of administration of redundant therapies and drugs to individual patients. The report   "   Global Patient Portal Market, By P...
Read more

Nuclear Medicine Market is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period

Image
  The Nuclear Medicine Market accounted for US$ 4.26 billion and is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period. Nuclear medicine may be a medicine involving the appliance of radioactive substances within the diagnosis and treatment of disease. Medicine imaging, during a sense, is "radiology done inside out" or "endoradiology" because it records radiation emitting from within the body instead of radiation that's generated by external sources like X-rays. Additionally, medicine scans differ from radiology, because the emphasis isn't on imaging anatomy, but on the function. For such reason, it's called a physiological imaging modality. Single photon emission computerized tomography (SPECT) and positron emission tomography (PET) scans are the 2 commonest imaging modalities in medicine.   The report "  Global Nuclear Medicine Market, By Diagnostics (Single Photon Emission, Computed Tomography (SPECT), an...
Read more

Knee Replacement Market is estimated to be 14.2 billion by 2029 with a CAGR of 4.3% during the forecasted period.

Image
  knee replacement market  accounted for 9.7 billion in 2020 and is estimated to be US$ 14.2 billion by 2029 and is anticipated to register a CAGR of 4.3%. The report " Global Knee Replacement Market, By Product ( Total Knee Replacement, Partial Knee Replacement, Kneecap Replacement, and Complex (or revision) Knee Replacement),  By End Users ( Hospitals, Orthopedic Centers, and Other ),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In March 2018, Smith and Nephew announced commercial release of bi-cruciate retaining Journey II XR total knee arthroplasty across the U.S. and Japan. The product launch was aimed at capturing large customer base with innovative product offering. In October 2018, Zimmer Biomet Holdings announced to collaborate with Apple to facilitate patient and surgeon connection during the knee and hip replacement procedures. Th...
Read more